PHARMANEMA
Timeline
32 events since 2002Board
Filings
Financial
Permits
Establishments
20052010201520202025
The 2026 accounts are due by 31-07-2027.
2026
Annual accounts 2025 filed NBBabbreviated format · 24 days before the deadline
2025
Annual accounts 2024 filed PDFabbreviated format · 20 days before the deadline
2024
Annual accounts 2023 filed PDFabbreviated format · 26 days before the deadline
2023
Highest result from 2006 to 2025 net €73,385 ▲47.9% The operating result of €88,550 and the net result of €73,385 are both a record.
Annual accounts 2022 filed PDFabbreviated format · 60 days before the deadline
Environmental permit granted Verbouwen en/of uitbreiden zonder functiewijziging en zonder wijziging van aantal woongelegenheden · Leuven
appointed as director acts as permanent representative · Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 03-03-20234 points ▸
- General meeting, 03-03-2023
- Director appointment, (director (not named in the articles))
- Permanent representative,
- Legal-form conversion, from private limited company (pre-2019) to private limited company
- The deed holds 3 more points.
2022
Annual accounts 2021 filed PDFabbreviated format · 45 days before the deadline
2021
Annual accounts 2020 filed PDFabbreviated format · 43 days before the deadline
2020
Annual accounts 2019 filed PDFabbreviated format · 7 days late
2019
Annual accounts 2018 filed PDFabbreviated format · 40 days before the deadline
2018
Equity above €200,000 equity €201,292 ▲0.8% After 11 profitable years in a row, equity reaches €201,292.
Annual accounts 2017 filed PDFabbreviated format · 53 days before the deadline
2017
Annual accounts 2016 filed PDFabbreviated format · 53 days before the deadline
2016
Annual accounts 2015 filed PDFabbreviated format · 65 days before the deadline
2015
Annual accounts 2014 filed PDFabbreviated format · 56 days before the deadline
2014
Annual accounts 2013 filed PDFabbreviated format · 65 days before the deadline
2013
Equity above €150,000 equity €167,917 ▲25.1% After 6 profitable years in a row, equity reaches €167,917.
Annual accounts 2012 filed PDFabbreviated format · 33 days before the deadline
2012
Annual accounts 2011 filed PDFabbreviated format · 49 days before the deadline
2011
Annual accounts 2010 filed PDFabbreviated format · 41 days before the deadline
2010
Annual accounts 2009 filed PDFabbreviated format · 18 days before the deadline
2009
Annual accounts 2008 filed PDFabbreviated format · 24 days before the deadline
2008
Back to profit net €23,998 The net result is €23,998, after one loss-making year.
Annual accounts 2007 filed PDFabbreviated format · 23 days before the deadline
2007
Weakest financial year net -€45,048 The net result drops to -€45,048, the lowest from 2006 to 2025. It recovers the following year.
Annual accounts 2006 filed PDFabbreviated format · 18 days before the deadline
2006
Annual accounts 2005 filed PDFabbreviated format
2005
Annual accounts 2004 filed PDFabbreviated format
2004
Annual accounts 2003 filed PDFabbreviated format
2003
First establishment APOTEEK, Albert Woutersstraat 9, Leuven
2002
Incorporation PDFpublished on 02-01-2003
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank